Arena Pharmaceuticals, Inc. - Common Stock (NQ:ARNA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 10, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arena Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 18, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Cannabis Stock Gainers And Losers From June 17, 2021 ↗

June 17, 2021

GAINERS: Invictus MD Strategies (OT...

Via Benzinga

Topics Cannabis

Steven Schoch Elected to Arena Pharmaceuticals Board of Directors

June 14, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Cannabis Stock Gainers And Losers From June 10, 2021 ↗

June 10, 2021

GAINERS: Cipher Pharms Inc (OTC:

Via Benzinga

Topics Cannabis

Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)

June 09, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO)

June 08, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

June 08, 2021

Via FinancialNewsMedia

Topics Cannabis Economy

Arena Pharmaceuticals Earns "A" Rating from MSCI ESG, a Leading Rating Agency for Sustainable Investments

June 03, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 19, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021 ↗

May 18, 2021

Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,...

Via Benzinga

Arena Pharmaceuticals Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments

May 12, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals Inc (ARNA) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

ARNA earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Arena Reports First Quarter Financial Results with Strong Cash Position and Continued Progress on Pipeline Over the Quarter

May 05, 2021

From ARENA Pharmaceuticals

Via Business Wire

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Arena Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Corporate Update on May 5

April 28, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2021 ↗

April 27, 2021

Upgrades According to JP Morgan, the prior rating for BP Midstream Partners LP (NYSE:BPMP) was changed from Neutral to Overweight. For the fourth quarter, BP Midstream...

Via Benzinga

Arena Pharmaceuticals Presents Clinician and Patient Reported Outcomes Data from Phase 2b ADVISE Trial Evaluating Etrasimod in Adult Atopic Dermatitis During a Late-Breaking Session at American Academy of Dermatology VMX

April 23, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report

April 19, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial During Late-Breaking Research Session at American Academy of Dermatology Virtual Meeting Experience

April 19, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 16, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.